Neonatal Cholestasis and Acholic Stools
A 3-week-old male infant is brought to your clinic with persistent jaundice and pale stools. He was born at 38 weeks via spontaneous vaginal delivery with a birth weight of 3.2 kg. He was breastfed initially but has been formula-fed for the past week due to poor latch. His mother reports that his stools have been pale yellow to white for the past 10 days, and his urine is dark. He is alert but has a slightly distended abdomen. Physical exam shows scleral icterus, a soft abdomen with the liver edge palpable 3 cm below the costal margin. Laboratory tests: total bilirubin 12 mg/dL, direct bilirubin 8 mg/dL (66%), ALT 120 U/L, AST 150 U/L, GGT 450 U/L, alkaline phosphatase 600 U/L. Coagulation studies are normal. Ultrasound shows a small gallbladder and no evidence of gallstones.
1. What is the most likely diagnosis, and what is the next best step in management?
Read the worked answer
The most likely diagnosis is biliary atresia, given the neonatal cholestasis (direct hyperbilirubinemia), acholic stools, hepatomegaly, and elevated GGT with normal coagulation. The ultrasound findings of a small gallbladder are consistent with biliary atresia, though not definitive. The next best step is hepatobiliary scintigraphy (HIDA scan) to assess bile duct patency, but in many centers, intraoperative cholangiogram is performed if suspicion is high. However, the definitive diagnosis requires liver biopsy and intraoperative cholangiogram. Given the classic presentation, urgent referral to a pediatric hepatologist and surgical planning for Kasai portoenterostomy is indicated. The timing is critical: surgery should be performed before 60 days of life to improve outcomes. Other causes like choledochal cyst, Alagille syndrome, and metabolic disorders should be considered, but the acholic stools and elevated GGT strongly point to biliary atresia.
2. What are the key prognostic factors for outcomes after Kasai procedure, and how would you counsel the family?
Read the worked answer
Key prognostic factors for Kasai portoenterostomy include age at surgery (best if <60 days), size and patency of bile ducts at the porta hepatis, absence of cirrhosis at time of surgery, and postoperative bile drainage. The family should be counseled that even with successful Kasai, many children eventually require liver transplantation. They should be informed about the need for long-term follow-up with a hepatologist, nutritional support (especially fat-soluble vitamins), and monitoring for complications like cholangitis and portal hypertension. The 5-year survival with native liver after Kasai is approximately 40-60%, and transplantation offers excellent long-term survival. The family should be prepared for the possibility of transplantation and the importance of adherence to medical therapy.